Literature DB >> 15951218

BMP antagonists: their roles in development and involvement in pathophysiology.

Motoko Yanagita1.   

Abstract

Bone morphogenetic proteins (BMPs) are phylogenetically conserved signaling molecules that belong to the transforming growth factor (TGF)-beta superfamily, and are involved in the cascades of body patterning and morphogenesis. The activities of BMPs are precisely regulated by certain classes of molecules that are recently recognized as BMP antagonists. BMP antagonists function through direct association with BMPs, thus prohibiting BMPs from binding their cognate receptors. In this review, the classification and functions of BMP antagonists will be discussed, especially focusing on the new family of tissue-specific BMP antagonists composed of uterine sensitization-associated gene 1 (USAG-1) and sclerostin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951218     DOI: 10.1016/j.cytogfr.2005.02.007

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  52 in total

Review 1.  Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells.

Authors:  Driss Zoukhri
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

2.  Bone morphogenetic protein signaling regulates the size of hair follicles and modulates the expression of cell cycle-associated genes.

Authors:  Andrey A Sharov; Tatyana Y Sharova; Andrei N Mardaryev; Alice Tommasi di Vignano; Ruzanna Atoyan; Lorin Weiner; Shi Yang; Janice L Brissette; G Paolo Dotto; Vladimir A Botchkarev
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 3.  Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates.

Authors:  David M Wiley; Suk-Won Jin
Journal:  Semin Cell Dev Biol       Date:  2011-10-12       Impact factor: 7.727

4.  Coupled global and targeted proteomics of human embryonic stem cells during induced differentiation.

Authors:  Anastasia K Yocum; Theresa E Gratsch; Nancy Leff; John R Strahler; Christie L Hunter; Angela K Walker; George Michailidis; Gilbert S Omenn; K Sue O'Shea; Philip C Andrews
Journal:  Mol Cell Proteomics       Date:  2008-02-26       Impact factor: 5.911

Review 5.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

6.  Maintenance of the BMP4-dependent stress erythropoiesis pathway in the murine spleen requires hedgehog signaling.

Authors:  John M Perry; Omid F Harandi; Prashanth Porayette; Shailaja Hegde; Arun K Kannan; Robert F Paulson
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

7.  Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.

Authors:  Linda Kim Pham; Mengmeng Liang; Helty A Adisetiyo; Chun-Peng Liao; Michael B Cohen; Stanley M Tahara; Baruch Frenkel; Noriyuki Kasahara; Pradip Roy-Burman
Journal:  Endocr Relat Cancer       Date:  2013-11-04       Impact factor: 5.678

8.  In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.

Authors:  Rodrigo Barderas; Marta Mendes; Sofia Torres; Rubén A Bartolomé; María López-Lucendo; Roi Villar-Vázquez; Alberto Peláez-García; Eduardo Fuente; Félix Bonilla; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

9.  Protein sequestration generates a flexible ultrasensitive response in a genetic network.

Authors:  Nicolas E Buchler; Frederick R Cross
Journal:  Mol Syst Biol       Date:  2009-05-19       Impact factor: 11.429

10.  Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anne I Boullerne; Jeffrey M Peters; Jill C Richardson; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2010-01-15       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.